Vaccine supply shortage comes at a bad time, as African countries make headway with their outbreaks and have seen good uptake ...

RSV, meningococcal, and chikungunya vaccine recommendations from the previous ACIP panel are now official policy.

First children vaccinated in clinical study seeking to expand the target population for the chikungunya vaccine. COPENHAGEN, Denmark, June 12, 2025 – Bavarian Nordic A/S (OMX: BAVA) announced today ...

First children vaccinated in clinical study seeking to expand the target population for the chikungunya vaccine. COPENHAGEN, Denmark, June 12, 2025 - Bavarian Nordic A/S (OMX: BAVA) announced ...

Paul Chaplin, President & CEO of Bavarian Nordic, said: “Upon the successful approvals earlier this year of our chikungunya vaccine for persons aged 12 and older, we are pleased to initiate this ...

First children vaccinated in clinical study seeking to expand the target population for the chikungunya vaccine. COPENHAGEN, Denmark, June 12, 2025 – Bavarian Nordic A/S (OMX: BAVA) announced today ...

They also recommended that a second chikungunya vaccine — Bavarian Nordic's Vimkunya — be made available for people age 12 and older who are traveling to countries where outbreaks of the ...

The UK approval of VIMKUNYA marks the third approval of Bavarian Nordic’s chikungunya vaccine, which was approved by the U.S. Food and Drug Administration (FDA) and the European Commission in February ...

The UK approval of VIMKUNYA marks the third approval of Bavarian Nordic’s chikungunya vaccine, which was approved by the U.S. Food and Drug Administration (FDA) and the European Commission in ...

The UK approval of VIMKUNYA marks the third approval of Bavarian Nordic’s chikungunya vaccine, which was approved by the U.S. Food and Drug Administration (FDA) and the European Commission in February ...

The UK approval of VIMKUNYA marks the third approval of Bavarian Nordic's chikungunya vaccine, which was approved by the U.S. Food and Drug Administration (FDA) and the European Commission in February ...

Press Release. March 16, 2025. 2. Bavarian Nordic. Bavarian Nordic Receives U.S. FDA Approval of Chikungunya Vaccine for Persons Aged 12 and Older. Press Release. Feb. 14, 2025. 3. EMA. Meeting ...